Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Kaposiform Hemangioendothelioma”

14 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 14 results

Testing effectiveness (Phase 2)Ended earlyNCT02110069
What this trial is testing

Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors

Who this might be right for
Kaposiform Hemangioendothelioma (KHE)Kasabach-Merritt SyndromeTufted Angioma
Boston Children's Hospital 4
Post-approval studies (Phase 4)Study completedNCT04448873
What this trial is testing

Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma

Who this might be right for
Kaposiform HemangioendotheliomaKasabach-Merritt Syndrome
Children's Hospital of Fudan University 30
Not applicableLooking for participantsNCT05351216
What this trial is testing

The Effect of Sirolimus on Immunizations During the Treatment of Kaposiform Hemangioendothelioma

Who this might be right for
Kaposiform Hemangioendothelioma
Children's Hospital of Fudan University 174
Post-approval studies (Phase 4)Looking for participantsNCT04921722
What this trial is testing

Percutaneous Administration of Sirolimus in the Treatment of Superficial Complicated Vascular Anomalies

Who this might be right for
Kaposiform HemangioendotheliomaTufted AngiomaSuperficial Vascular Anomalies+1 more
Children's Hospital of Fudan University 75
Post-approval studies (Phase 4)Study completedNCT04077515
What this trial is testing

Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma

Who this might be right for
HemangiomaKaposiform Hemangioendothelioma
Children's Hospital of Fudan University 92
Testing effectiveness (Phase 2)Study completedNCT03188068
What this trial is testing

Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma

Who this might be right for
Kaposiform HemangioendotheliomaKasabach Merritt Phenomenon
West China Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07131644
What this trial is testing

Sirolimus Discontinuation Strategies in Kaposiform Hemangioendothelioma

Who this might be right for
Kaposiform Hemangioendothelioma
West China Hospital 120
Testing effectiveness (Phase 2)Study completedNCT00975819
What this trial is testing

Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies

Who this might be right for
Kaposiform HemangioendotheliomasTufted AngiomaCapillary Venous Lymphatic Malformation+6 more
Denise Martin Adams 61
Testing effectiveness (Phase 2)UnknownNCT05324384
What this trial is testing

Different Doses of Sirolimus for the Maintenance Treatment of Kaposiform Hemangioendothelioma

Who this might be right for
Hemangioendothelioma
West China Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT04056962
What this trial is testing

Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma

Who this might be right for
Tacrolimus, Kaposiform Hemangioendothelioma, Tufted Angioma
West China Hospital 50
Not applicableLooking for participantsNCT02399527
What this trial is testing

Lymphatic Anomalies Registry for the Assessment of Outcome Data

Who this might be right for
Lymphatic MalformationGeneralized Lymphatic Anomaly (GLA)Central Conducting Lymphatic Anomaly+7 more
Boston Children's Hospital 1,000
Testing effectiveness (Phase 2)Study completedNCT04775173
What this trial is testing

Efficacy and Safety of Different Concentrations of Sirolimus in the Treatment of Kaposiform Hemangioendothelioma.

Who this might be right for
Kaposiform Hemangioendothelioma
West China Hospital 79
Early research (Phase 1)UnknownNCT04409691
What this trial is testing

SCMC Trial on KHE With KMP (V.2020)

Who this might be right for
Kaposiform Hemangioendothelioma (KHE) With Kasabach-Merritt Phenomenon (KMP)
Shanghai Children's Medical Center 20
Not applicableLooking for participantsNCT03001180
What this trial is testing

Identification of Biomarkers for Patients with Vascular Anomalies

Who this might be right for
Vascular AnomalyGeneralized Lymphatic AnomalyKaposiform Hemangioendothelioma+4 more
Children's Hospital Medical Center, Cincinnati 1,000